Cell therapies for neurological disease – from bench to clinic to bench

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.5, Iss.3, 2005-03, pp. : 289-291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adecatumumab: an anti-EpCAM monoclonal antibody, from the bench to the bedside

By Kurtz Jean-Emmanuel Dufour Patrick

Expert Opinion on Biological Therapy, Vol. 10, Iss. 6, 2010-06 ,pp. : 951-958

Informa Healthcare

Access to resources Recommend Favorite

Challenges for the translation of T cell costimulatory blockade therapies to the clinic

By Sayegh Mohamed H Salama Alan D

Expert Opinion on Biological Therapy, Vol. 2, Iss. 5, 2002-06 ,pp. : 453-457

Informa Healthcare

Access to resources Recommend Favorite

DNA sequencing: bench to bedside and beyond

By Hutchison Clyde A.

Nucleic Acids Research, Vol. 35, Iss. 18, 2007-09 ,pp. : 6227-6237

Oxford University Press

Access to resources Recommend Favorite

IL-12/IL-2 combination cytokine therapy for solid tumours: translation from bench to bedside

By Wiltrout Robert H Wigginton Jon M

Expert Opinion on Biological Therapy, Vol. 2, Iss. 5, 2002-06 ,pp. : 513-524

Informa Healthcare

Access to resources Recommend Favorite

Oxygen-controlled Biosurfactant Production in a Bench Scale Bioreactor

By Kronemberger Frederico de Santa Anna Lidia Fernandes Ana Menezes Reginaldo Borges Cristiano Freire Denise

Applied Biochemistry and Biotechnology, Vol. 147, Iss. 1-3, 2008-03 ,pp. : 33-45

Humana Press, Inc

Access to resources Recommend Favorite